Tumor suppressor gene co-operativity in compound Patched1 and suppressor of fused heterozygous mutant mice.
Dysregulation of the Hedgehog signaling pathway is central to the development of certain tumor types, including medulloblastoma and basal cell carcinoma (BCC). Patched1 (Ptch1) and Suppressor of fused (Sufu) are two essential negative regulators of the pathway with tumor suppressor activity. Ptch1(+/-) mice are predisposed to developing medulloblastoma and rhabdomyosarcoma, while Sufu(+/-) mice develop a skin phenotype characterized by basaloid epidermal proliferations. Here, we have studied tumor development in Sufu(+/-)Ptch1(+/-) mice to determine the effect of compound heterozygosity on the onset, incidence, and spectrum of tumors. We found significantly more (2.3-fold) basaloid proliferations in Sufu(+/-)Ptch1(+/-) compared to Sufu(+/-) female, but not male, mice. For medulloblastoma, the cumulative 1-yr incidence was 1.5-fold higher in Sufu(+/-)Ptch1(+/-) compared to Ptch1(+/-) female mice but this strong trend was not statistically significant. Together this suggests a weak genetic interaction of the two tumor suppressor genes. We noted a few rhabdomyosarcomas and pancreatic cysts in the Sufu(+/-)Ptch1(+/-) mice, but the numbers were not significantly different from the single heterozygous mice. Hydrocephalus developed in approximately 20% of the Ptch1(+/-) and Sufu(+/-)Ptch1(+/-) but not in Sufu(+/-) mice. Interestingly, most of the medulloblastomas from the Sufu(+/-)Ptch1(+/-) mice had lost expression of the remaining Ptch1 wild-type allele but not the Sufu wild-type allele. On the contrary, Sufu as well as Gli1 and Gli2 expression was upregulated in the medulloblastomas compared to adult cerebellum in Ptch1(+/-) and Sufu(+/-)Ptch1(+/-) mice. This suggests that Sufu expression may be regulated by Hedgehog pathway activity and could constitute another negative feedback loop in the pathway.
Svärd
Jessica
J
Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Rozell
Björn
B
Toftgård
Rune
R
Teglund
Stephan
S
D000818:Animals; D005260:Female; D016147:Genes, Tumor Suppressor; D007150:Immunohistochemistry; D008297:Male; D008527:Medulloblastoma / Q000235:genetics; D051379:Mice; D018345:Mice, Knockout; D008817:Mice, Mutant Strains; D000072079:Patched Receptors; D000072081:Patched-1 Receptor; D011956:Receptors, Cell Surface / Q000235:genetics*; D012097:Repressor Proteins / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction
C000606236:PTCH1 protein, human; D000072079:Patched Receptors; D000072081:Patched-1 Receptor; C000606240:Ptch1 protein, mouse; D011956:Receptors, Cell Surface; D012097:Repressor Proteins; C490764:SUFU protein, human
Nat Rev Genet. 2006 Nov;7(11):841-50
17047684
Dev Cell. 2006 Feb;10(2):187-97
16459298
J Biol Chem. 2000 Sep 15;275(37):28341-4
10884376
Nat Cell Biol. 1999 Sep;1(5):312-9
10559945
Nat Rev Cancer. 2003 Dec;3(12):903-11
14737121
Cancer Res. 2001 Jan 15;61(2):513-6
11212243
Development. 2005 May;132(10):2425-39
15843415
Nature. 2003 Oct 23;425(6960):851-6
14520413
Cancer Res. 2006 Feb 15;66(4):2081-8
16489008
Oncogene. 2007 Sep 27;26(44):6442-7
17452975
Development. 1999 Oct;126(20):4431-40
10498679
J Pathol. 2006 Jan;208(1):17-25
16294371
PLoS Biol. 2006 Apr;4(4):e86
16602821
Genes Dev. 2001 Dec 1;15(23):3059-87
11731473
Oncogene. 2002 Oct 24;21(49):7580-4
12386820
Nat Med. 1999 Nov;5(11):1285-91
10545995
Nat Genet. 2002 Jul;31(3):306-10
12068298
Neuropathol Appl Neurobiol. 2004 Oct;30(5):532-9
15488029
Nat Cell Biol. 2007 Sep;9(9):1005-9
17762891
Cancer Cell. 2004 Sep;6(3):229-40
15380514
Science. 1997 Aug 22;277(5329):1109-13
9262482
Cell. 1996 Jun 14;85(6):841-51
8681379
Cancer Res. 2000 Apr 15;60(8):2239-46
10786690
Nat Clin Pract Oncol. 2007 May;4(5):295-304
17464337
Science. 2002 Aug 30;297(5586):1559-61
12202832
Cancer Res. 2006 Jul 15;66(14):6964-71
16849540
Genet Med. 2004 Nov-Dec;6(6):530-9
15545751
Oncogene. 2006 Sep 7;25(40):5575-80
16636673
Cancer Res. 2006 Oct 15;66(20):10171-8
17047082
Science. 1996 Jun 14;272(5268):1668-71
8658145
Nat Med. 1998 May;4(5):619-22
9585239
Development. 2005 Oct;132(19):4407-17
16155214